Business
Zomedica to Present at the OTCQB Venture Virtual Investor Conference August 7th
Zomedica to Present at the OTCQB Venture Virtual Investor Conference August 7th.
About this update from Zomedica Corp.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Zomedica to Present at the OTCQB Venture Virtual Investor Conference August 7th\r\n \r\n \r\n\r\n\r\nZomedica to Present at the OTCQB Venture Virtual Investor Conference August 7th\r\nCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com\r\n\r\n\r\n\r\n\r\n\r\nANN ARBOR, Mich., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Zomedica Corp. (OTCQB: ZOMDF) (\"Zomedica\" or the \"Company\"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will present live at the OTCQB Venture Virtual Investor Conference hosted by VirtualInvestorConferences.com, on August 7th, 2025 DATE: August 7th TIME: 1:30 PM ETLINK: REGISTER HEREAvailable for 1x1 meetings: August 7–8, 2025 This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.   Learn more about the event at www.virtualinvestorconferences.com. About Zomedica Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® Loop line of therapeutic devices, along with the TRUFORMA® diagnostic platform, TRUVIEW® digital cytology system, VETGuardian® no-touch monitoring system, and VETIGEL® hemostatic gel, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds $2 billion. Headquartered in Michigan, Zomedica employs approximately 150 people and manufactures and distributes its products from its world-class facilities in Georgia and Minnesota. Zomedica grew revenue 8% in 2024 to $27 million and maintains a stro...